Review



dhrs9  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Proteintech dhrs9
    Dhrs9, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 166 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dhrs9/pm41665627-121-19-21?v=Proteintech
    Average 94 stars, based on 166 article reviews
    dhrs9 - by Bioz Stars, 2026-07
    94/100 stars

    Images



    Similar Products

    flag tagged dhrs9 pcmv tag4a  (New England Biolabs)
    99
    New England Biolabs flag tagged dhrs9 pcmv tag4a
    Flag Tagged Dhrs9 Pcmv Tag4a, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dhrs9/pmc12538056-189-10-19?v=New+England+Biolabs
    Average 99 stars, based on 1 article reviews
    flag tagged dhrs9 pcmv tag4a - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier
    sh dhrs9  (Obio Technology Corp Ltd)
    86
    Obio Technology Corp Ltd sh dhrs9
    Sh Dhrs9, supplied by Obio Technology Corp Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dhrs9/pm42296784-100-15-17?v=Obio+Technology+Corp+Ltd
    Average 86 stars, based on 1 article reviews
    sh dhrs9 - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    dhrs9  (Proteintech)
    94
    Proteintech dhrs9
    Dhrs9, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dhrs9/pm41665627-121-19-21?v=Proteintech
    Average 94 stars, based on 1 article reviews
    dhrs9 - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    sirnas targeting dhrs9  (Sangon Biotech)
    86
    Sangon Biotech sirnas targeting dhrs9
    <t>DHRS9</t> expression levels correlate with overall survival in ovarian cancer patients. Kaplan–Meier curves were constructed from GEPIA ( a ) and KMplot ( b ) databases. Patients with higher DHRS9 expression exhibited reduced survival times relative to those with lower expression
    Sirnas Targeting Dhrs9, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dhrs9/pmc12390911-28-0-13?v=Sangon+Biotech
    Average 86 stars, based on 1 article reviews
    sirnas targeting dhrs9 - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    anti dhrs9  (Novus Biologicals)
    93
    Novus Biologicals anti dhrs9
    <t>DHRS9</t> expression levels correlate with overall survival in ovarian cancer patients. Kaplan–Meier curves were constructed from GEPIA ( a ) and KMplot ( b ) databases. Patients with higher DHRS9 expression exhibited reduced survival times relative to those with lower expression
    Anti Dhrs9, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dhrs9/pm40864320-57-47-50?v=Novus+Biologicals
    Average 93 stars, based on 1 article reviews
    anti dhrs9 - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    gene exp dhrs9 hs00608375 m1  (Thermo Fisher)
    85
    Thermo Fisher gene exp dhrs9 hs00608375 m1
    <t>DHRS9</t> expression levels correlate with overall survival in ovarian cancer patients. Kaplan–Meier curves were constructed from GEPIA ( a ) and KMplot ( b ) databases. Patients with higher DHRS9 expression exhibited reduced survival times relative to those with lower expression
    Gene Exp Dhrs9 Hs00608375 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dhrs9/us12378525-667-17-5?v=Thermo+Fisher
    Average 85 stars, based on 1 article reviews
    gene exp dhrs9 hs00608375 m1 - by Bioz Stars, 2026-07
    85/100 stars
    		  Buy from Supplier

    Image Search Results


    DHRS9 expression levels correlate with overall survival in ovarian cancer patients. Kaplan–Meier curves were constructed from GEPIA ( a ) and KMplot ( b ) databases. Patients with higher DHRS9 expression exhibited reduced survival times relative to those with lower expression

    Journal: Journal of Cancer Research and Clinical Oncology

    Article Title: DHRS9 promotes malignant progression of ovarian cancer through SQSTM1

    doi: 10.1007/s00432-025-06290-y

    Figure Lengend Snippet: DHRS9 expression levels correlate with overall survival in ovarian cancer patients. Kaplan–Meier curves were constructed from GEPIA ( a ) and KMplot ( b ) databases. Patients with higher DHRS9 expression exhibited reduced survival times relative to those with lower expression

    Article Snippet: siRNAs targeting DHRS9 and SQSTM1 were synthesized by JTSBIO Co., Ltd. (China) and Sangon Biotech (China), respectively.

    Techniques: Expressing, Construct

    Effects of DHRS9 knockdown on aggressive phenotypes and apoptosis of A2780 cells. a , b qRT-PCR and western blot evaluating mRNA and protein expression of DHRS9 in IOSE-80, A2780 and OVCAR-3 cell lines. c , d qRT-PCR and western blot verification of DHRS9 knockdown efficiency. e , f CCK-8 and colony formation assays examining the effects of DHRS9 depletion on A2780 cell growth. g , h Transwell assays assessing the impact of DHRS9 knockdown on A2780 cell migration and invasion capabilities. i Flow cytometry-based apoptosis detection in DHRS9-silencing A2780 cells.Data are shown as mean ± SD. Scale bar = 200 μm. ** P < 0.01; *** P < 0.001;**** P < 0.0001

    Journal: Journal of Cancer Research and Clinical Oncology

    Article Title: DHRS9 promotes malignant progression of ovarian cancer through SQSTM1

    doi: 10.1007/s00432-025-06290-y

    Figure Lengend Snippet: Effects of DHRS9 knockdown on aggressive phenotypes and apoptosis of A2780 cells. a , b qRT-PCR and western blot evaluating mRNA and protein expression of DHRS9 in IOSE-80, A2780 and OVCAR-3 cell lines. c , d qRT-PCR and western blot verification of DHRS9 knockdown efficiency. e , f CCK-8 and colony formation assays examining the effects of DHRS9 depletion on A2780 cell growth. g , h Transwell assays assessing the impact of DHRS9 knockdown on A2780 cell migration and invasion capabilities. i Flow cytometry-based apoptosis detection in DHRS9-silencing A2780 cells.Data are shown as mean ± SD. Scale bar = 200 μm. ** P < 0.01; *** P < 0.001;**** P < 0.0001

    Article Snippet: siRNAs targeting DHRS9 and SQSTM1 were synthesized by JTSBIO Co., Ltd. (China) and Sangon Biotech (China), respectively.

    Techniques: Knockdown, Quantitative RT-PCR, Western Blot, Expressing, CCK-8 Assay, Migration, Flow Cytometry

    Effects of DHRS9 overexpression on aggressive phenotypes and apoptosis of OVCAR-3 cells. a , b qRT-PCR and western blot analysis verification of DHRS9 overexpression efficiency. c , d CCK-8 and colony formation assays examining the effects of DHRS9 overexpression on OVCAR-3 cell growth. e , f Transwell assays assessing the impact of DHRS9 overexpression on OVCAR-3 cell migration and invasion capabilities. g Analysis of apoptosis via flow cytometry in DHRS9-overexpressing OVCAR-3 cells. Data are shown as mean ± SD. Scale bar = 200 μm. ** P < 0.01; *** P < 0.001;**** P < 0.0001

    Journal: Journal of Cancer Research and Clinical Oncology

    Article Title: DHRS9 promotes malignant progression of ovarian cancer through SQSTM1

    doi: 10.1007/s00432-025-06290-y

    Figure Lengend Snippet: Effects of DHRS9 overexpression on aggressive phenotypes and apoptosis of OVCAR-3 cells. a , b qRT-PCR and western blot analysis verification of DHRS9 overexpression efficiency. c , d CCK-8 and colony formation assays examining the effects of DHRS9 overexpression on OVCAR-3 cell growth. e , f Transwell assays assessing the impact of DHRS9 overexpression on OVCAR-3 cell migration and invasion capabilities. g Analysis of apoptosis via flow cytometry in DHRS9-overexpressing OVCAR-3 cells. Data are shown as mean ± SD. Scale bar = 200 μm. ** P < 0.01; *** P < 0.001;**** P < 0.0001

    Article Snippet: siRNAs targeting DHRS9 and SQSTM1 were synthesized by JTSBIO Co., Ltd. (China) and Sangon Biotech (China), respectively.

    Techniques: Over Expression, Quantitative RT-PCR, Western Blot, CCK-8 Assay, Migration, Flow Cytometry

    Interaction between DHRS9 and SQSTM1. a Co-IP verification of the direct interaction between DHRS9 and SQSTM1 proteins. b , c Western blot analysis of SQSTM1 protein expression following DHRS9 overexpression and knockdown. Data are shown as mean ± SD. * P < 0.05;*** P < 0.001;**** P < 0.0001

    Journal: Journal of Cancer Research and Clinical Oncology

    Article Title: DHRS9 promotes malignant progression of ovarian cancer through SQSTM1

    doi: 10.1007/s00432-025-06290-y

    Figure Lengend Snippet: Interaction between DHRS9 and SQSTM1. a Co-IP verification of the direct interaction between DHRS9 and SQSTM1 proteins. b , c Western blot analysis of SQSTM1 protein expression following DHRS9 overexpression and knockdown. Data are shown as mean ± SD. * P < 0.05;*** P < 0.001;**** P < 0.0001

    Article Snippet: siRNAs targeting DHRS9 and SQSTM1 were synthesized by JTSBIO Co., Ltd. (China) and Sangon Biotech (China), respectively.

    Techniques: Co-Immunoprecipitation Assay, Western Blot, Expressing, Over Expression, Knockdown

    In vivo DHRS9 knockdown suppresses tumor growth in a xenograft model. a Representative images of subcutaneous tumors from nude mice injected with A2780 cells. b Final tumor weights. c Tumor growth curves showing inhibition of tumor progression following DHRS9 knockdown. d , e Western blot analysis confirming decreased DHRS9 and SQSTM1 protein expression in tumor tissues from the treatment group. Data are shown as mean ± SD. ** P < 0.01; *** P < 0.001

    Journal: Journal of Cancer Research and Clinical Oncology

    Article Title: DHRS9 promotes malignant progression of ovarian cancer through SQSTM1

    doi: 10.1007/s00432-025-06290-y

    Figure Lengend Snippet: In vivo DHRS9 knockdown suppresses tumor growth in a xenograft model. a Representative images of subcutaneous tumors from nude mice injected with A2780 cells. b Final tumor weights. c Tumor growth curves showing inhibition of tumor progression following DHRS9 knockdown. d , e Western blot analysis confirming decreased DHRS9 and SQSTM1 protein expression in tumor tissues from the treatment group. Data are shown as mean ± SD. ** P < 0.01; *** P < 0.001

    Article Snippet: siRNAs targeting DHRS9 and SQSTM1 were synthesized by JTSBIO Co., Ltd. (China) and Sangon Biotech (China), respectively.

    Techniques: In Vivo, Knockdown, Injection, Inhibition, Western Blot, Expressing